Vol 1, No 1 (September 01, 2012): Chinese Clinical Oncology

Editorial

Chinese Clinical Oncology: a new oncology journal for oncology physicians and researchers worldwide
Charles M. Balch
Chinese Clinical Oncology  
2012;
1
(1)
:1
.
 (01 September 2012) 
PDF Full Text (2304) Open Access Get Permission
Medical oncology in Asia
Kazuo Tamura
Chinese Clinical Oncology  
2012;
1
(1)
:2
.
 (01 September 2012) 
PDF Full Text (5759) Open Access Get Permission
Advanced clinical trials for China
Richard L. Schilsky
Chinese Clinical Oncology  
2012;
1
(1)
:3
.
 (01 September 2012) 
PDF Full Text (2525) Open Access Get Permission

Perspective

Serum Dickkopf-1 as a biomarker for the diagnosis of hepatocellular carcinoma
Jen-Eing Jeng, Lea-Yea Chuang, Wan-Lung Chuang, Jung-Fa Tsai
Chinese Clinical Oncology  
2012;
1
(1)
:4
.
 (01 September 2012) 
PDF Full Text (5571) Open Access Get Permission
Who will be the next rising star? —— Any hope to find a reliable biomarker for HCC?
Edmund K.K. Tung, Irene O.L. Ng
Chinese Clinical Oncology  
2012;
1
(1)
:5
.
 (01 September 2012) 
PDF Full Text (2989) Open Access Get Permission
Vitamin E: potential therapeutical approach for prevention of liver cancer development
Marine Baptissart, Aurelie Vega, Jean-Marc A. Lobaccaro, David H. Volle
Chinese Clinical Oncology  
2012;
1
(1)
:6
.
 (01 September 2012) 
PDF Full Text (4966) Open Access Get Permission
Vitamin intake and risk of liver cancer: potential for prevention?
Sabrina Schlesinger, Ute Nöthlings
Chinese Clinical Oncology  
2012;
1
(1)
:7
.
 (01 September 2012) 
PDF Full Text (7059) Open Access Get Permission
Vitamin E in prevention against hepatocellular carcinoma: right type, right dose and right population
Stephen L. Chan, Brigette B.Y. Ma
Chinese Clinical Oncology  
2012;
1
(1)
:8
.
 (01 September 2012) 
PDF Full Text (5994) Open Access Get Permission
Hepatocellular carcinoma: expanding the horizon
Roberto A. Pazo-Cid, Javier Fuentes, Luis Sarriá, José M. Artigas, Jesús Esarte
Chinese Clinical Oncology  
2012;
1
(1)
:9
.
 (01 September 2012) 
PDF Full Text (4611) Open Access Get Permission

Guidelines and Expert Consensus

Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition)
Primary Liver Cancer Diagnosis Treatment Expert Panel
Chinese Clinical Oncology  
2012;
1
(1)
:10
.
 (01 September 2012) 
PDF Full Text (130610) Open Access Get Permission
Expert consensus on local ablation therapies for primary liver cancer
Meng-Chao Wu, Zhao-You Tang, Sheng-Long Ye, Jia Fan, Shu-Kui Qin, Jia-Mei Yang, Min-Shan Chen, Min-Hua Chen, Ming-De Lv, Kuan-Sheng Ma, Yu-Lian Wu, Yi Chen, Guo-Jun Qian, Shi-Chun Lu, Jia-Sheng Zheng, Wen-Bing Sun, Ying-Hua Zou, Hui-Min Liang, Zhi-Yong Huang, Xin-Wei Han, Xiang Jing, Hong-Ming Pan, Tian-An Jiang, Ping Liang, Zheng-Gang Ren, Yao-Jun Zhang
Chinese Clinical Oncology  
2012;
1
(1)
:11
.
 (01 September 2012) 
PDF Full Text (4794) Open Access Get Permission
Expert consensus on the scheme of pathological diagnosis of primary liver cancer
Wen-Ming Cong, Xi-Qi Hu, Yun-Tian Sun, Yun-Shan Tan, Xiao-Long Ji, Jing-Ping Yun, Hong-Guang Zhu, Hui Guo, Rui-Aan Wang, Su-Xiang Liu, Hong-Lin Yin, Xi Wang, Zeng-Shan Li, Yuan Ji
Chinese Clinical Oncology  
2012;
1
(1)
:12
.
 (01 September 2012) 
PDF Full Text (5370) Open Access Get Permission

Perspective

Current status of bevacizumab for advanced hepatocellular carcinoma
Catherine T. Frenette
Chinese Clinical Oncology  
2012;
1
(1)
:13
.
 (01 September 2012) 
PDF Full Text (8376) Open Access Get Permission
Hepatocellular carcinoma: present and future
Gaetano Bertino
Chinese Clinical Oncology  
2012;
1
(1)
:14
.
 (01 September 2012) 
PDF Full Text (8125) Open Access Get Permission
Guidelines for the management of hepatocellular carcinoma: still in need of standardization
Angelo Sangiovanni, Massimo Colombo
Chinese Clinical Oncology  
2012;
1
(1)
:15
.
 (01 September 2012) 
PDF Full Text (3018) Open Access Get Permission